|
Market Closed -
Nasdaq Stockholm
09:30:00 23/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.310 SEK | +1.32% |
|
+0.87% | +2.21% |
| 20/08 | Lärkberget AB Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 21/04 | Larkberget to carry out rights issue of units totaling SEK 14.9 mln | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMBIGENE AB | Bio Therapeutic Drugs | +1.32% | +0.87% | +2.21% | -10.81% | -83.36% | 45.51L |  | |  |
- Stock Market
- Stocks
- LARK Stock
- Charts CombiGene AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
